Researchers found a reason why COVID-19 may be life-threatening

University of Tartu researchers participated in a study published in Science, indicating that about 10 per cent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself. Another recently published study showed that another 3.5 per cent of such patients carry a specific kind of genetic mutation. In both cases, the patients did not have type I interferons that are essential in protection against viruses. Read More

A novel treatment combination for lung cancer studied in Tartu

Medical researchers of the University of Tartu and doctors of Tartu University Hospital have an ambitious plan to take their novel combination of stereotactic body radiotherapy and immunotherapy to treatment guidelines and thus reach suitable patients suffering from lung cancer. Up to 20 lung cancer patients will be included in the study SynAct Lung to assess the safety and efficiency of the new combination.

Read More

Probiotic ME-3 bacteria find their way into chocolate

ME-3, or the probiotic lactic acid bacterium Lactobacillus fermentum, has formed part of the Estonian diet for 17 years as an ingredient in Hellus dairy products, and has also been available as a food supplement since 2014. Now these highly beneficial bacteria have found their way into chocolate, in a new product launched in March by the internationally renowned Estonian chocolate artisans Chocolala in cooperation with researchers from the University of Tartu.

Read More